Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders (NCT05656469)
A New Intervention for Implementation of Pharmacogenetics in Psychiatry
🩺 Plain-English Summary (8th-Grade Level)
A 24-week, patient- and rater-blinded, two-arm, parallel-group controlled, and multi-centre randomized clinical trial (RCT) to establish the benefits of pharmacogenetics-informed pharmacotherapy versus dosing as usual (DAU) in psychiatric patients suffering from mood, anxiety, or psychotic disorders.
Who can join: Review the eligibility criteria below.
Location: SUNY Upstate Medical University, Department of Psychiatry and Behavioural Sciences — Syracuse, New York
Age range: 16 Years to 70 Years
🧪 Interventions in This Study
- Personalised medication advice based on pharmacogenetic testing (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- SUNY Upstate Medical University, Department of Psychiatry and Behavioural Sciences — Syracuse, New York
- University Hospital Bonn, Department of Psychiatry and Psychotherapy — Bonn,
- Ludwig-Maximilian University, University Hospital, Institute of Psychiatric Phenomics and Genomics (IPPG) — München,
- Parnassia Psychiatric Institute, Department of Psychiatry — Amsterdam,
- Maastricht University, Department of Psychiatry and Neuropsychology — Maastricht,
- Babeş-Bolyai University, Department of Clinical Psychology and Psychotherapy — Cluj-Napoca,
- University of Belgrade, Faculty of Pharmacy — Belgrade,
- Fundació Clínic per a la Recerca Biomèdica, Department of Psychiatry and Psychology, Hospital Clínic — Barcelona,
- King's College, Institute of Psychiatry, Psychology & Neuroscience — London,
📞 Contact the Study Coordinator
Phone: +31 883583398
Email: r.vanwestrhenen@psyq.nl
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Mood Disorders
- Brain, Emotions, and Mind-Wandering — Pittsburgh, Pennsylvania
- Reconnecting to Ourselves and Others in Virtual Meetings (ROOM) — Charlestown, Massachusetts
- Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers — Bethesda, Maryland
- I-CARE: A Pilot Study of Cognitive Behavioural Therapy(CBT) for Mood and Anxiety Disorders — Toronto, Ontario
- RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty — Monroeville, Pennsylvania
- Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders — Bethesda, Maryland
Explore by condition: All Mood Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.